Trial Profile
An open label pharmacokinetic and pharmacodynamic study of tolvaptan in patients with renal impairment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Renal impairment
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Otsuka Pharmaceutical Development & Commercialization
- 09 Dec 2015 New trial record